Transcriptomics

Dataset Information

0

Blockade of histamine receptor H1 augments immune checkpoint therapy by enhancing MHC-I expression in pancreatic cancer cells


ABSTRACT: Although immune checkpoint blockade (ICB) therapy has proven to be extremely effective in managing certain cancers, its efficacy in pancreatic ductal adenocarcinoma (PDAC) remains limited. Previous studies have indicated that histamine and histamine receptor H1 (HRH1) can suppress immunity by affecting immune cells. This study uncovered an unexplored role of HRH1 intrinsic to tumor cells in PDAC. When HRH1 specific to tumor cells was inhibited in PDAC mouse models, there was a noticeable increase in MHC-I expression in these cells via the activation of cholesterol biosynthesis signaling. This augmented the infiltration and efficacy of cytotoxic CD8+ T cells, synergizing anticancer immunity and mitigating resistance to ICB treatment. Our results highlight that HRH1 plays an immunosuppressive role in cancer cells. Consequently, HRH1 intervention may be a promising method to amplify the responsiveness of PDAC to immunotherapy.

ORGANISM(S): Homo sapiens

PROVIDER: GSE251639 | GEO | 2023/12/26

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2020-11-14 | GSE161484 | GEO
2022-08-28 | GSE211726 | GEO
2013-12-01 | E-GEOD-41585 | biostudies-arrayexpress
2020-08-03 | GSE154136 | GEO
2017-06-01 | GSE74446 | GEO
2020-03-22 | GSE147333 | GEO
2006-07-27 | GSE5385 | GEO
2022-07-11 | ST002216 | MetabolomicsWorkbench
2022-07-11 | ST002217 | MetabolomicsWorkbench
2013-12-01 | GSE41585 | GEO